Research Funding Opportunities
Crohn’s and Colitis Canada application forms now require Adobe Reader or Professional (version 8 or higher) for assembling and submitting applications as pdf files. You can find the latest free version of Adobe Reader here.
Grants-in-Aid of Research
The Crohn’s and Colitis Canada Grants-in-Aid of Research program is intended to support research on inflammatory bowel disease (IBD). This research program helps to advance prevention, treatments, health policy and to ultimately find cures.
GIA’s support research projects with a defined objective, conducted by an investigator working alone or in collaboration with others. Grants will be awarded for a maximum of three years, not to exceed $125,000 per annum. A grant of $5,000, provided in partnership with CIHR’s the Institute of Nutrition, Metabolism and Diabetes’ (INMD), may be awarded as a one-time lump sum to the highest ranked project from a new investigator. This funding would help support travel and ancillary costs for the individual to attend or speak at gastroenterology conferences or to purchase essential equipment necessary to their study.
November 14th – Letter of Intent online application. [PDF] Adobe Acrobat reader will be required to complete this application form. Click here for download. Please be advised that the Letter of Intent form cannot be saved nor submitted online. It must be downloaded and submitted both electronically (via email) and in hard copy (vial mail).
Please click the following to find the Grants in Aid of Research 2017 forms:
Please note we need to receive an electronic copy and a print copy of your full application. Electronic applications should be emailed to firstname.lastname@example.org Please reference "LOI for Grants-in-Aid of Research 2017" in the subject line when submitting Letters of Intent. Printed copies should be mailed to their attention at the address below:
600-60 St. Clair Avenue East
Investigators who hold an academic appointment at a Canadian University in a Faculty of Medicine, Nursing, Pharmacy, Veterinary Medicine or other Graduate Faculty are eligible to apply to Crohn’s and Colitis Canada as principal investigators for grant support of their research. The research proposed must have a clear connection to the mission of our organization. Co-Investigators based in the United States are acceptable.
If an applicant does not hold an academic appointment at the time of submitting an application, a covering letter from the Dean of the Faculty must be attached to the application, indicating the planned position and the date it will take effect. Investigators in Faculties other than the health sciences may also apply if the proposed research is deemed relevant to Crohn’s and Colitis Canada’s mission and strategic directions.
If the research is to be done in a hospital or other health care facility, the signature of that institution’s officer on the first page of the application certifies that appropriate space and resources are available, and will be provided to the applicant.
Support for qualified undergraduate and graduate students within the operating budget is permissible. In order to be eligible to receive funding for a GIA from Crohn’s and Colitis Canada, recipients must be members of the Crohn’s and Colitis Canada IBD Research Institute.
To qualify for the new investigator prize, individuals must have held a full-time research appointment for a period up to sixty months from the initial faculty appointment.
Each application is assessed for its scientific merit, relevancy and translatability potential by the Grants Review Committee (GRC). Applications may also be independently reviewed by external referees who are considered expert in the field(s) concerned.
Crohn’s and Colitis Canada incorporates lay reviewers on its Grant Review Committee (GRC) panel in order to increase accountability and transparency of the review process and to ensure the research is aligned with its goals and mission. The lay reviewers help shed light on the relevancy of the proposal to Crohn’s and Colitis Canada’s mission. We place a high priority on ensuring appropriate lay summaries are submitted as part of each application.
The committee discusses the application and by consensus (or by majority vote if necessary) assigns it a score between 0 and 5. These scores represent the following categories: OUTSTANDING (4.5-4.9), EXCELLENT (4.0-4.4), VERY GOOD (3.5-3.9), ACCEPTABLE BUT LOW PRIORITY (3.0-3.4), or UNACCEPTABLE (<2.9). This assignment is based on the Committee members’ assessments of the application in light of the discussion, consideration of the application itself, the reports of the internal reviewers and the external referees. Each member of the GRC who has participated in the discussion (excluding GRC members from the same institution or otherwise in conflict) then assigns to the application a score within a range of +0.5 of the consensus score. An average of these submitted scores then determines the final score and rank. Only those proposals receiving a score in the range of good or better (3.5 or above) are discussed in detail by the GRC. In addition, relevancy to the mission of Crohn’s and Colitis Canada and prospect for translatability is considered in the overall rating. Those deemed not relevant or translatable would be unacceptable and therefore rejected.
The Grants Review Committee is also required to recommend a budget or appropriate level of funding for each application. This is decided by consensus within the committee. In arriving at a recommended budget, Crohn’s and Colitis Canada’s National Board of Directors expects that the Grants Review Committee will bring its collective judgment and knowledge of research requirements and costs. It should consider closely the budget submitted by the applicant and recommend funding that will permit the applicant(s) to make reasonable progress over the period of the grant. This recommendation of the budget is separate and distinct from the assessment of scientific merit and is made subsequent to that assessment.
In accordance with Board direction, our program priorities and budgetary constraints, Crohn’s and Colitis Canada, informed by the Grants Review Committee, considers the ratings and the recommended budgets and announces the final decision. There will be no appeals of these decisions.
Click here to see a list of the projects we are currently funding.BACK TO TOP
Innovations in IBD Research
Crohn's and Colitis Canada invites applications for an "Innovations Grant", to fund novel or innovative approaches to IBD research. This grant is intended to stimulate and support research which may not be encompassed within the boundaries of traditional medical research. Research proposals must conform to sound principles of research and may aim to collect pilot data for follow-on application(s). Our organization seeks mission relevance and excellence as well as innovation.
Grants to a maximum of $50,000 for one year may be awarded.
Please note that at this time we are unable to directly fund Principal investigators (PI’s) outside Canada.
Electronic applications should be emailed to email@example.com and printed copies should be mailed to their attention at the address below:
Research Funding Partnerships
Research funding through partnered programs is also available. Visit the Research Funding Partnerships to learn more.BACK TO TOP
2017 IBD NURSING EDUCATIONAL TRAVEL AWARDS
CANIBD is a community of practice within CSGNA. It was created to advance mentoring and support for IBD nursing in Canada. The 2017 IBD nursing educational travel awards are being launched to provide learning and mentorship opportunities for IBD nurses in Canada. The 2017 IBD nursing educational travel awards may be granted to Canadian nurses who wish to attend an IBD-related medical conference.
The goal of these awards is to support nurses to learn, network, share best practices, and keep abreast of developments in IBD research and care that will improve or inform patient care and/or quality of life.
Subject to the availability of funds, up to three awards (maximum value of $1,000 CAD each) will be granted in 2017. Funding support for these awards has been provided by industry partners: AbbVie, Janssen, Shire, and Takeda.
ELIGIBILITY & REVIEW PROCESS
Any nurse engaged in IBD research or care in Canada is eligible to apply. Applicants must register with Crohn’s and Colitis Canada (click here) and must be a current active member of CSGNA. All applications will be evaluated for eligibility and reviewed by a nursing selection committee, comprised of a minimum of two CANIBD steering committee members without any direct conflict-of-interest. All committee decisions are final. Applicants may apply for the award once every two years.
Applications should be made in the form of a one-page letter including a short description of:
In addition, a supporting letter from the head of the appropriate department of the applicant's institution is required confirming that the applicant meets the eligibility criteria.
Completed applications (including supporting documentation) should be emailed to firstname.lastname@example.org The deadline for applications is February 1st, 2017.
Nurses are responsible for coordinating their own conference registration, transportation and accommodation. In order to be reimbursed for up to $1,000 in eligible expenses, the recipient must submit the following after attending the conference:
Questions concerning this award may be directed to:
Nursing-Led IBD Research Grant
Crohn’s and Colitis Canada in partnership with CANIBD (A CSGNA community of practice) has launched the Nursing-led IBD Research Grant. This grant is intended to increase funding opportunities for nurses leading research projects in IBD and develop research skills within the IBD nursing community. The goal of this grant is to support a small clinical research pilot project that will improve or inform IBD patient care and/or quality of life for IBD patients.
This grant is for one-year with a total value of $15,000 CAD.
Eligibility & Review Process
Any nurse, affiliated with a Canadian hospital or university, engaged in IBD research or care in Canada is an eligible Principal Applicant for this award. Principal applicants must register with the Crohn’s and Colitis Canada IBD Research Institute (to join send an email request to email@example.com) and must be a current active member of CSGNA. There can be only one nurse listed as the Principal Investigator for each proposal. The applicant institution must be a non-profit, charitable institution, such as a university, hospital or research organization. Applications will be assessed for eligibility and reviewed by a nursing selection committee, comprised of the Research Chair of the Crohn’s and Colitis Canada Scientific & Medical Advisory Council, and a minimum of two practitioners (e.g., CANIBD steering committee members with direct knowledge and expertise in the subject area of the proposed project) without any direct conflict-of-interest.
Nursing-Led IBD Research Competition 2017